V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody
169€ (20 µg)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx110352
tested applications
ELISA, IHC, IF/ICC
Description
V-set domain-containing T-cell activation inhibitor 1 Antibody is a Rabbit Polyclonal antibody against V-set domain-containing T-cell activation inhibitor 1.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | Target: V-Set Domain-Containing T-Cell Activation Inhibitor 1 (VTCN1) Immunogen: Recombinant human V-set domain-containing T-cell activation inhibitor 1 protein (26-258AA). |
| Host | Rabbit |
| Reactivity | Human |
| Recommended Dilution | IHC: 1/20 - 1/200, IF/ICC: 1/50 - 1/200. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purity | > 95% |
| Purification | Purified by Protein G. |
| Size 1 | 20 µg |
| Size 2 | 50 µg |
| Size 3 | 100 µg |
| Size 4 | 200 µg |
| Size 5 | 1 mg |
| Form | Liquid |
| Tested Applications | ELISA, IHC, IF/ICC |
| Buffer | 0.01 M PBS, pH 7.4, 0.03% Proclin-300 and 50% Glycerol. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| UniProt ID | Q7Z7D3 |
| Gene ID | 79679 |
| NCBI Accession | NP_001240778.1, NM_001253849.1 |
| OMIM | 608162 |
| Background | Antibody anti-VTCN1 |
| Status | RUO |
| Note | THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION. |
Descripción
Related Products
Human VTCN1 (V-set domain-containing T-cell activation inhibitor 1) ELISA Kit
Ver Producto
VTCN1 antibody
Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells(Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.
Ver Producto